Molnupiravir Treatment for COVID-19 in People at Higher Risk in the Community: Outcomes from the PANORAMIC Randomised Controlled Trial at Three and Six Months

Harris V., Holmes J., Gbinigie O., Rahman NM., Richards D., Hayward G., Dorward J., Lowe D., Standing J., Breuer J., Khoo S., Petrou S., Hood K., Ahmed H., Carson-Stevens A., Nguyen-Van-Tam J., Patel M., Saville B., Francis N., Thomas NBP., Evans P., Dobson M., Png ME., Lown M., van Hecke O., Jani B., Hart N., Butler D., Cureton L., Patil M., Andersson M., Coates M., Williams S., Bateman C., Davies J., Raymundo-Wood I., Ustianowski A., Yu L-M., Hobbs R., Little P., Butler C., Group PANORAMICTC.

Type

Preprint

Publication Date

2026-05-29T00:00:00+00:00

Keywords

Long term follow-up, SARS-CoV-2, Randomized controlled trial, Primary Care, COVID-19

Permalink Close